We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Sunday
May 04
15:15 - 16:15
Stolz 2
Lower GI 3
Corrie Marijnen, The Netherlands;
David Sebag-Montefore, United Kingdom
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
GI
15:15 - 15:21
MRI-guided stereotactic radiotherapy: a new frontier for peritoneal oligometastases
Angela Romano, Italy
E25-3860
15:21 - 15:27
SABR with fruquintinib and tislelizumab in metastatic colorectal cancer: Updated findings from a single-arm, prospective phase II trial (RIFLE)
Fan Xia, China
E25-2620
15:27 - 15:33
Impact of thermoradiation short course radiotherapy on locally advanced rectal cancer (LARC): Prospective phase II trial.
Barbara Gabriela Salas Salas, Spain
E25-929
15:33 - 15:39
THUNDER 2 - Theragnostic utilities for neoplastic diseases of the rectum by MRI-guided radiotherapy - Phase II study: definitive results
Giuditta Chiloiro, Italy
E25-4065
15:39 - 15:45
Neoadjuvant treatment of rectal cancer: A UK-wide audit after implementation of national IMRT guidance
Rebecca Muirhead, United Kingdom
E25-1539
15:51 - 15:57
Dose-effect relationship on response rates and toxicity in total neoadjuvant therapy for locally advanced rectal cancer – A multicenter analysis
Georg Wurschi, Germany
E25-2229
15:57 - 16:03
Patient experience assessment with serial sampling for research in rectal cancer radiotherapy trials: use of the Decision Regret Scale.
Ross McMahon, United Kingdom
E25-1624
16:09 - 16:15
Outcomes after (chemo)radiotherapy for anal cancer – a nationwide cohort study
Maaike Berbee, The Netherlands
E25-3848